Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03740191Not ApplicableTerminated
Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
Intermediate Risk Prostate CancerLow Risk Prostate Cancer
PrincipalinvestigatorStart date: 2018-07-03

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

EBG MedAustron GmbH

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Duncan B McLaren, MBBS

NHS Lothian & University of Edinburgh

Moderately Similar
1 trials

Shared therapeutic areas:

Intermediate Risk Prostate CancerLow Risk Prostate Cancer
Similarity Score30%

Levent Kabasakal, Prof. MD

Istanbul University - Cerrahpasa

Related
1 trials

Shared therapeutic areas:

Low Risk Prostate Cancer
Similarity Score15%

Adrian VS Hill

University of Oxford

Related
3 trials

Shared therapeutic areas:

Intermediate Risk Prostate Cancer
Similarity Score15%

Andrew Protheroe

Nuffield Department of Surgical Sciences, Oxford University Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Intermediate Risk Prostate Cancer
Similarity Score15%

Freddie Hamdy

Nuffield Department of Surgical Sciences, Oxford University Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Intermediate Risk Prostate Cancer
Similarity Score15%

Peter Hoskin

Department of Oncology, The Christie NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Intermediate Risk Prostate Cancer
Similarity Score15%

Gwenaelle Gravis, MD

Institut Paoli-Calmettes

Related
5 trials

Shared therapeutic areas:

Low Risk Prostate Cancer
Similarity Score15%

Mark Tuthill

Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Intermediate Risk Prostate Cancer
Similarity Score15%

Glenn Bubley, MD

Beth Israel Deaconess Medical Center

Related
3 trials

Shared therapeutic areas:

Intermediate Risk Prostate Cancer
Similarity Score15%

Bryan Burmeister

Trans Tasman Radiation Oncology Group

Related
1 trials

Shared therapeutic areas:

Intermediate Risk Prostate Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03740191Not ApplicablePrincipalInvestigator

Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer

Intermediate Risk Prostate CancerLow Risk Prostate Cancer
Terminated

All 1 trials loaded